InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Cavanaugh Sarah, Directeur des Affaires Corporatives. Insider active across 1 company, notably Celldex Therapeutics, Inc.. Aggregated, 4 filings have been published. History available since 1 November 2021. The latest transaction was filed on 8 December 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations4 total
1,857 shares@ US$9.01650.0006% mcap27.5% of flowCommon StockSEC:0001179110-21-010820
1,857 shares@ US$9.01650.0006% mcap13.7% of flowCommon StockSEC:0001179110-21-010820:0
5,018 shares@ US$9.01650.0016% mcap36.3% of flowCommon StockSEC:0001179110-21-009818:0
5,018 shares@ US$9.01650.0016% mcap72.5% of flowCommon StockSEC:0001179110-21-009818
4 of 4 declarations
About Cavanaugh Sarah
Sarah Cavanaugh is Senior Vice President of Corporate Affairs and Administration at Celldex Therapeutics, Inc. She oversees corporate affairs initiatives and ensures regulatory compliance. Her role is essential for the strategic development of the company.
